Perrigo Company plc (PRGO) Sells Dermacosmetics Unit in 327M Deal

In this article, we will be taking a look at the 12 Cheap Healthcare Stocks to Buy Now. Perrigo Company plc is one of them.

Perrigo Company plc (NYSE:PRGO), a global healthcare supplier, specializes in over-the-counter (OTC) and self-care products, generic prescription pharmaceuticals, and active pharmaceutical ingredients. The company is known for its private-label consumer health products sold through major retailers such as Walmart, Amazon, Costco, and CVS, with key brands including Opill, Mederma, Compeed, EllaOne, and Jungle Formula.

Perrigo Company plc (NYSE:PRGO) advanced its strategic plan to “Stabilize, Streamline, and Strengthen” by divesting non-core businesses. A notable move is the sale of its Dermacosmetics branded business to KKR-managed Kairos Bidco AB for up to €327 million, expected to close in Q1 2026. The divestiture reflects the company’s focus on its core self-care and private-label consumer health offerings.

Leadership confidence was also evident through insider purchases in early September, with executives such as EVP Charles Atkinson and Chief Scientific Officer Lennox Abigail acquiring shares worth $23,200. Such activity underscores management’s belief in the company’s growth prospects.

Perrigo Company plc (NYSE:PRGO)’s senior management, including President and CEO Patrick Lockwood-Taylor, participated in the Barclays Global Consumer Staples Conference, highlighting ongoing investor engagement and transparency regarding strategic direction and product pipeline.

While we acknowledge the potential of PRGO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure. None.